4.6 Article

Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 24, Issue 12, Pages 3840-3846

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfp455

Keywords

comorbidity; end-stage renal disease; ethnicity; survival; transplantation

Ask authors/readers for more resources

Introduction. Accurate assessment of determinants of patient survival in end-stage renal disease is important for counselling, clinical management and resource planning. To address this we have analysed survival and risk factors for survival for patients treated for end-stage renal disease in a multi-ethnic UK population. Methods. A multicentre prospective observational cohort study was performed in four teaching hospital renal units serving a total population of four million people. A total of 884 consecutive patients treated with renal replacement therapy were studied. Cox proportional hazard modelling and adjusted survival curves were used to assess the impact of a range of variables on patients surviving dialysis for more than 90 days. Further analysis was undertaken to determine the likelihood of transplantation in different ethnic groups. Results. Survival was 29% after a mean and median follow up of 4.6 and 4.2 years, respectively. Factors associated with worse survival included the following: age; for each decade of life the relative risk (RR) of death was 1.52 (95% confidence intervals 1.41-1.65, p < 0.0001); comorbidity, one or two comorbid conditions, RR = 1.56 (95% CI 1.24-1.95, p < 0.001) and three or more comorbid conditions, RR = 2.34 (1.68-3.27, p < 0.001). Factors associated with better survival included the following: south-Asian ethnicity, RR = 0.6 (0.46-0.80, p < 0.001); renal transplantation, RR = 0.20 (95% CI 0.11-0.59, p < 0.0001) and glomerulonephritis as the primary renal disease, RR = 0.70 (0.50-0.97, p = 0.04). Factors associated with likelihood of transplantion were having a functioning fistula/peritoneal dialysis catheter at start of dialysis (RR 1.91, 95% CI 1.24-2.94, p = 0.003) and glomerulonephritis (RR 9.54, 95% CI 2.43-37.64, p = 0.001). Patients were less likely to receive if they were black (RR 0.10, 95% CI 0.02-0.34, p < 0.001), South Asian (RR 0.64, 95% CI 0.42-0.97, p = 0.037), diabetic (RR 0.06, 95% CI 0.01-0.23, p < 0.001) and had one or two comorbid conditions (RR 0.51, 95% CI 0.32-0.82, p = 0.06). Every decade increase in age was also associated with a lesser likelihood of transplantation (RR 0.55, 95% CI 0.49-0.61, p < 0.001). Discussion. Risk stratification at commencement of chronic dialysis may predict long-term survival in different patient groups. As expected ethnic minorities are less likely to receive a transplant and this should be addressed by the new waiting list prioritization. The better survival on dialysis in this population of patients with south-Asian ethnicity is unexplained and this requires further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients

Federica Genovese, Daniel Guldager Kring Rasmussen, Morten A. Karsdal, Mark Jesky, Charles Ferro, Anthony Fenton, Paul Cockwell

Summary: This study found that dynamic products of COL3 formation and degradation were independently associated with CKD progression and mortality, providing the opportunity to link pathological processes with targeted treatments against fibrosis.

CLINICAL KIDNEY JOURNAL (2021)

Article Dentistry, Oral Surgery & Medicine

Oxidative stress links periodontal inflammation and renal function

Praveen Sharma, Anthony Fenton, Irundika H. K. Dias, Brenda Heaton, Caroline L. R. Brown, Amneet Sidhu, Mutahir Rahman, Helen R. Griffiths, Paul Cockwell, Charles J. Ferro, Iain L. Chapple, Thomas Dietrich

Summary: The study found a causal relationship between periodontal inflammation and renal function, mediated by systemic oxidative stress. Periodontal inflammation represents an occult source of oxidative stress in patients with CKD, and periodontal therapy may potentially improve outcomes in CKD by reducing systemic inflammatory/oxidative stress burden.

JOURNAL OF CLINICAL PERIODONTOLOGY (2021)

Article Transplantation

The effect of admission and pre-admission serum creatinine as baseline to assess incidence and outcomes of acute kidney injury in acute medical admissions

Luke Pickup, Charalampos Loutradis, Jonathan P. Law, Julia J. Arnold, Indranil Dasgupta, Pantelis Sarafidis, Jonathan N. Townend, Paul Cockwell, Charles J. Ferro

Summary: This study evaluated the incidence of acute kidney injury using pre-admission and admission creatinine levels and found that even minor increases in creatinine levels were associated with increased mortality. This can help clinicians identify patients at higher risk for adverse outcomes.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Urology & Nephrology

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD

Chava L. Ramspek, Marie Evans, Christoph Wanner, Christiane Drechsler, Nicholas C. Chesnaye, Maciej Szymczak, Magdalena Krajewska, Claudia Torino, Gaetana Porto, Samantha Hayward, Fergus Caskey, Friedo W. Dekker, Kitty J. Jager, Merel van Diepen

Summary: The study validates existing kidney failure risk prediction models in patients with advanced CKD, finding that some models perform well in the short term but overestimate risk in longer-term predictions due to competing risks. The Grams model, which accounts for competing risks, is suitable for longer-term predictions.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Editorial Material Urology & Nephrology

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action

Anna Francis, Colin Baigent, T. Alp Ikizler, Paul Cockwell, Vivekanand Jha

KIDNEY INTERNATIONAL (2021)

Review Urology & Nephrology

Kidney injury and disease in patients with haematological malignancies

Frank Bridoux, Paul Cockwell, Ilya Glezerman, Victoria Gutgarts, Jonathan J. Hogan, Kenar D. Jhaveri, Florent Joly, Samih H. Nasr, Deirdre Sawinski, Nelson Leung

Summary: Patients with haematological cancer are at a higher risk of kidney injury, either as a direct result of the malignancy or due to treatment-related effects. It is common for cancer patients, especially those with haematological malignancies, to experience acute kidney injury (AKI) which can be caused by the underlying blood disorder.

NATURE REVIEWS NEPHROLOGY (2021)

Article Endocrinology & Metabolism

Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history

Charalampos Loutradis, Luke Pickup, Jonathan P. Law, Indranil Dasgupta, Jonathan N. Townend, Paul Cockwell, Adnan Sharif, Pantelis Sarafidis, Charles J. Ferro

Summary: Men are at higher risk of AKI and AKI-related mortality, independent of existing risk factors for AKI. However, the association between male sex and AKI-related mortality is not independent from existing comorbidities.

BIOLOGY OF SEX DIFFERENCES (2021)

Article Urology & Nephrology

Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom

Harjeet K. Bhachu, Paul Cockwell, Anuradhaa Subramanian, Nicola J. Adderley, Krishna Gokhale, Anthony Fenton, Derek Kyte, Krishnarajah Nirantharakumar, Melanie Calvert

Summary: The study found that using a risk-based referral approach can lead to a significant reallocation of patients between primary care and specialist nephrology care, ensuring that those at higher risk of progression are identified and treated more promptly.

KIDNEY INTERNATIONAL REPORTS (2021)

Review Medicine, General & Internal

Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review

Harjeet Kaur Bhachu, Anthony Fenton, Paul Cockwell, Olalekan Aiyegbusi, Derek Kyte, Melanie Calvert

Summary: This systematic review evaluated the impact of the Kidney Failure Risk Equation (KFRE) in clinical practice. Five studies were included in the analysis, showing conflicting evidence on the impact of KFRE on patient referrals and wait times. Further studies are needed to assess the impact of KFRE on clinical care.

BMJ OPEN (2022)

Article Peripheral Vascular Disease

Is there a role of the kidney failure risk equation in optimizing timing of vascular access creation in pre-dialysis patients?

Kulli Kuningas, Stephanie Stringer, Paul Cockwell, Aurangzaib Khawaja, Nicholas Inston

Summary: This study assessed the use of KFRE as an indicator for timing vascular access creation in pre-dialysis patients. The study found that the predictive models were relatively poor in determining the initiation of dialysis, resulting in a high rate of unnecessary fistula formation and non-use of fistulas.

JOURNAL OF VASCULAR ACCESS (2022)

Article Medicine, General & Internal

Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease

Derek Kyte, Nicola Anderson, Jon Bishop, Andrew Bissell, Elizabeth Brettell, Melanie Calvert, Marie Chadburn, Paul Cockwell, Mary Dutton, Helen Eddington, Elliot Forster, Gabby Hadley, Natalie J. Ives, Louise J. Jackson, Sonia O'Brien, Gary Price, Keeley Sharpe, Stephanie Stringer, Rav Verdi, Judi Waters, Adrian Wilcockson

Summary: This study aimed to assess the feasibility and acceptability of online electronic patient-reported outcome measures (ePROMs) in patients with chronic kidney disease (CKD). The results showed that this approach is feasible and patients are willing to participate, and the intervention was considered acceptable. However, measures to improve longer-term engagement are needed.

BMJ OPEN (2022)

Article Urology & Nephrology

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients

Chava L. Ramspek, Rosemarijn Boekee, Marie Evans, Olof Heimburger, Charlotte M. Snead, Fergus J. Caskey, Claudia Torino, Gaetana Porto, Maciej Szymczak, Magdalena Krajewska, Christiane Drechsler, Christoph Wanner, Nicholas C. Chesnaye, Kitty J. Jager, Friedo W. Dekker, Maarten G. J. Snoeijs, Joris Rotmans, Merel van Diepen

Summary: This study validated the predictive performance of the CKD G4thorn risk calculator in patients with kidney disease and assessed its clinical impact in guiding vascular access placement. The results showed accurate predictions and using the model to guide referral for vascular access placement can reduce unnecessary surgeries.

KIDNEY INTERNATIONAL REPORTS (2022)

Article Medical Informatics

Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods

Z. Yonel, K. Kuningas, P. Sharma, M. Dutton, Z. Jalal, P. Cockwel, J. Webber, P. Narendran, T. Dietrich, I. L. C. Chapple

Summary: The POCT devices demonstrated acceptable concordance with laboratory-based assays, and patients reported lower levels of discomfort compared to traditional means of blood collection.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Article Multidisciplinary Sciences

Mesenchymal stromal cell therapy compared to SGLT2-inhibitors and usual care in treating diabetic kidney disease: A cost-effectiveness analysis

Luke E. Barry, Grainne E. Crealey, Paul Cockwell, Stephen J. Elliman, Matthew D. Griffin, Alexander P. Maxwell, Timothy O'Brien, Norberto Perico, Ciaran O'Neill

Summary: This study simulated the cost-effectiveness of Mesenchymal Stromal Cell therapy compared to other treatments in patients with Diabetic Kidney Disease. The results showed that Mesenchymal Stromal Cell therapy was more cost-effective compared to other treatments. However, sodium/glucose co-transporter 2 inhibitors had the highest cost-effectiveness among all the treatments.

PLOS ONE (2022)

Article Respiratory System

Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area

Elizabeth Sapey, Suzy Gallier, Chris Mainey, Peter Nightingale, David McNulty, Hannah Crothers, Felicity Evison, Katharine Reeves, Domenico Pagano, Alastair K. Denniston, Krishnarajah Nirantharakumar, Peter Diggle, Simon Ball

BMJ OPEN RESPIRATORY RESEARCH (2020)

No Data Available